TyRx Inc. announced that it has received a license from Health Canada to market its AigisRx Antibacterial Envelope. The AigisRx Envelope is specifically designed to stabilize pacemakers and implantable cardioverter defibrillators (ICD) while also releasing antimicrobial agents to help provide protection from microbial colonization of the device during surgical implantation.

October 11, 2012 — Spectranetics Corp. announced the U.S. market launch of the Tapas catheter at the 2012 Vascular Interventional Advances (VIVA) conference in Las Vegas. Tapas is manufactured by ThermopeutiX Inc. and distributed by Spectranetics.

October 11, 2012 — Edwards Lifesciences Corp. announced it has completed the acquisition of BMEYE B.V., a privately held Dutch company that specializes in the development of noninvasive technology for advanced hemodynamic monitoring.

October 11, 2012 — With this month’s approval of the Standards and Guidelines for Advanced Cardiovascular Sonography by the Commission on Accreditation for Allied Health Education Programs (CAAHEP), experienced cardiovascular sonographers have a new educational pathway for career advancement.

Boston Scientific Corporation has begun the United States and European launch of its Victory guidewire, designed to facilitate crossing of resistant lesions and the placement and exchange of balloon catheters or other interventional devices within the peripheral vasculature.  The company expects to launch the product in other international markets later this year and in 2013, subject to regulatory approvals.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now